How cocaine use and stopping affects sleep and daily rhythms
Official title: Longitudinal Exploration of Subjective and Objective Sleep Characteristics in Patients With Cocaine Use Disorder During the Withdrawal Process
Run by Hôpital le Vinatier · NCT07119567 · Data updated 2026-11-12
This study tries to see how cocaine use and stopping change sleep and circadian rhythms in adults entering supervised inpatient detoxification.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 32 (estimated) |
| Sponsor | Hôpital le Vinatier Academic / other |
| Locations | 3 sites (Bron, AURA and 2 other locations) |
| Status | Recruiting |
| Started | March 19, 2026 |
| Main results expected | September 15, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | June 11, 2026 |
| Trial ID | NCT07119567 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) who meet DSM-5 criteria for cocaine use disorder, have a positive urine test for cocaine, and are scheduled for supervised inpatient detoxification within the next four weeks with valid contact information and national health coverage.
✕Probably not a fit
People with current opioid or other psychostimulant use disorders, unstable psychiatric or medical conditions, those taking certain medications (e.g., methylphenidate, modafinil, melatonin, naltrexone, bupropion), pregnant or breastfeeding women, or patients under legal guardianship are unlikely to be eligible or benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study follows people with cocaine use disorder through three phases: active use, early withdrawal, and late withdrawal during supervised inpatient detoxification. It uses ambulatory polysomnography (Somfit®) over two nights per visit, continuous actigraphy, repeated sleep questionnaires, and frequent urinary biomarkers (free cortisol and 6-sulfatoxymelatonin) to capture objective and subjective sleep and circadian measures. The design permits analysis of sleep macro- and microstructure, the integrity of the circadian system, and day-to-day sleep–wake timing. By linking these multimodal measures, the study aims to explore whether sleep changes predict longer-term withdrawal outcomes.
Why it matters
Potential benefit: If successful, the results could identify sleep or circadian markers that help target interventions and reduce relapse risk during recovery from cocaine dependence.
How similar studies have gone: Previous work has used actigraphy and polysomnography in substance use disorders, but detailed monitoring of sleep microstructure and circadian biomarkers specifically across cocaine withdrawal phases is relatively novel with limited prior evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female, aged 18 years or older * Meeting DSM-5 criteria for cocaine use disorder * Positive urine drug screen for cocaine * Scheduled for inpatient supervised cocaine detoxification within the next four weeks * Covered by a national health insurance plan or social security system * Have a valid, personal means of contact (telephone or email address) enabling remote follow-up at 6 months. Exclusion Criteria: * Current diagnosis of opioid use disorder or other psychostimulant use disorders (e.g., amphetamines, methamphetamines, cathinones, methylphenidate) * Unstable psychiatric disorder or somatic illness deemed incompatible with study participation by the investigator * Current treatment with methylphenidate, modafinil, solriamfetol, melatonin, pitolisant, naltrexone, or bupropion * Patients under legal guardianship * Pregnant or breastfeeding women: a pregnancy test will be performed prior to inclusion for women of childbearing potential * Individuals deprived of liberty by judicial or administrative decision
Where it's running
-
Centre Hospitalier Le Vinatier
Bron, Auvergne-Rhône-Alpes, France Recruiting -
CH Le Vinatier
Bron, France Recruiting -
Centre Hospitalier Le Vinatier
Bron, Aura, France Not yet recruiting
Study contacts
- Principal investigator: BENJAMIN ROLLAND, MD, PhD — Centre Hospitalier le Vinatier
- Study coordinator: ILONA MEDIGUE, PhD student
- Email: ilona.medigue@ch-le-vinatier.fr
- Phone: 00334 37 91 55 65
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HD-tDCS during CBT for Cocaine Use Disorder
This study tests whether adding high-definition transcranial direct current stimulation to cognitive behavioral therapy helps adults with cocaine use disorder see if CBT works better.
-
Imaging Brain Mitochondrial Complex-I in Cocaine Use Disorder
This study uses a PET scan with [F-18]BCPP-EF to see how mitochondrial Complex-I activity in the brain differs between people with cocaine use disorder and healthy controls.
-
Mild electrical brain stimulation (tDCS) with cognitive training to reduce cocaine cravings.
This trial will test whether brief sessions of mild electrical brain stimulation (tDCS) combined with cognitive reappraisal training can lower craving in adults receiving inpatient treatment for cocaine use disorder.
-
Clonidine to reduce craving in hospitalized people with cocaine or crack use disorder
This will try clonidine versus clonazepam to see if clonidine lowers craving in people hospitalized for cocaine or crack use disorder.
-
Semaglutide plus cognitive behavioral therapy for cocaine use disorder
This trial will test whether adding semaglutide (a GLP-1 medication) to cognitive behavioral therapy helps adults with cocaine use disorder reduce craving and use.
-
Cue-reactivity incubation and cognitive reappraisal in cocaine use disorder
This project will see if practicing cognitive reappraisal reduces cue-triggered brain responses and cravings in people with cocaine use disorder who are early in abstinence.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.